Rothfuss Cristin 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
2025-03-04$101.34/sh−288$29,186→ 13,037 total - Tax Payment
Common Stock
2025-03-04$101.34/sh−296$29,997→ 13,325 total
Footnotes (1)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.